Stockreport

Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year [Yahoo! Finance]

Catheter Precision, Inc.  (VTAK) 
PDF products for cardiac electrophysiology, including its VIVO and LockeT products, has announced a major expansion in its business development team. The company is bolsteri [Read more]